AbbVie secures FDA approval for Rinvoq as the first oral Janus kinase inhibitor indicated for giant cell arteritis, expanding ...

RO is a DTP telehealth company that provides nationwide services. The company offers multiple GLP-1 options and has hired a ...

After announcing successful trial results for its lead mRNA treatment earlier this year, Regulus Therapeutics agreed to be ...